PNTG Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $297.98M; Selling, general and administrative $21.61M; Income tax $3.94M; Net income $9.08M.
- 2026-03-31: Revenue $285.36M; Selling, general and administrative $19.69M; Income tax $3.79M; Net income $8.52M.
- 2025-12-31: Revenue $289.32M*; Selling, general and administrative $19.34M*; Income tax $3.90M*; Net income $8.64M*.
- 2025-09-30: Revenue $229.04M; Selling, general and administrative $19.30M; Income tax $2.52M; Net income $6.08M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Major Customers
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $297.98M | $21.61M | $3.94M | $9.08M |
| 2026-03-31 | $285.36M | $19.69M | $3.79M | $8.52M |
| 2025-12-31 | $289.32M* | $19.34M* | $3.90M* | $8.64M* |
| 2025-09-30 | $229.04M | $19.30M | $2.52M | $6.08M |
| 2025-06-30 | $219.50M | $17.60M | $2.60M | $7.08M |
| 2025-03-31 | $209.84M | $14.84M | $2.85M | $7.78M |
| 2024-09-30 | $180.69M | $13.02M | $1.35M | $6.21M |
| 2024-06-30 | $168.75M | $11.88M | $1.84M | $5.69M |
| 2024-03-31 | $156.91M | $11.44M | $1.76M | $4.91M |
| 2023-09-30 | $140.19M | $9.42M | $1.07M | $4.38M |
| 2023-06-30 | $132.28M | $8.79M | $1.92M | $2.80M |
| 2023-03-31 | $126.46M | $8.71M | $907.00K | $1.85M |
| 2022-09-30 | $118.35M | $5.88M | $1.07M | $4.83M |
| 2022-06-30 | $116.32M | $9.74M | -$1.38M | -$2.68M |
| 2022-03-31 | $113.91M | (m) | $542.00K | $1.01M |
| 2021-09-30 | $111.92M | (m) | $69.00K | $1.25M |
| 2021-06-30 | $110.34M | (m) | $604.00K | $2.65M |
| 2021-03-31 | $105.66M | (m) | $340.00K | $950.00K |
| 2020-09-30 | $98.40M | (m) | $104.00K | $4.41M |
| 2020-06-30 | $92.74M | (m) | $1.44M | $4.34M |
| 2020-03-31 | $91.85M | (m) | $889.00K | $2.98M |
| 2019-09-30 | $88.40M | (m) | $123.00K | $1.52M |
| 2019-06-30 | $82.73M | (m) | -$375.00K | $3.49M |
| 2019-03-31 | $77.91M | (m) | $343.00K | $1.33M |
| 2018-09-30 | $72.95M | (m) | $1.39M | $4.37M |
| 2018-06-30 | (m) | (m) | (m) | $4.16M |
| 2018-03-31 | (m) | (m) | (m) | $3.38M |
Revenue and expense 6 month
| Period end | Revenue | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $583.35M | $41.30M | $7.73M | $17.60M |
| 2025-06-30 | $429.34M | $32.44M | $5.45M | $14.86M |
| 2024-06-30 | $325.66M | $23.31M | $3.60M | $10.60M |
| 2023-06-30 | $258.75M | $17.50M | $2.83M | $4.65M |
| 2022-06-30 | $230.23M | $19.77M | -$833.00K | -$1.66M |
| 2021-06-30 | $216.01M | (m) | $944.00K | $3.60M |
| 2020-06-30 | $184.59M | (m) | $2.33M | $7.32M |
| 2019-06-30 | $160.64M | (m) | -$32.00K | $4.82M |
Revenue and expense 9 month
| Period end | Revenue | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|
| 2025-09-30 | $658.38M | $51.73M | $7.97M | $20.94M |
| 2024-09-30 | $506.35M | $36.34M | $4.96M | $16.80M |
| 2023-09-30 | $398.94M | $26.91M | $3.89M | $9.03M |
| 2022-09-30 | $348.58M | $25.65M | $241.00K | $3.17M |
| 2021-09-30 | $327.93M | (m) | $1.01M | $4.84M |
| 2020-09-30 | $282.99M | (m) | $2.43M | $11.72M |
| 2019-09-30 | $249.04M | (m) | $91.00K | $6.34M |
| 2018-09-30 | $210.72M | (m) | $3.59M | $11.91M |
Revenue and expense 12 month
| Period end | Revenue | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|
| 2025-12-31 | $947.71M | $71.08M | $11.87M | $29.58M |
| 2024-12-31 | $695.24M | $50.21M | $7.03M | $22.56M |
| 2023-12-31 | $544.89M | $36.67M | $5.67M | $13.38M |
| 2022-12-31 | $473.24M | $33.98M | $1.65M | $6.64M |
| 2021-12-31 | $439.69M | $36.26M | $582.00K | $2.70M |
| 2020-12-31 | $390.95M | (m) | $2.35M | $15.74M |
| 2019-12-31 | $338.53M | (m) | $2.08M | $2.55M |
| 2018-12-31 | $286.06M | (m) | $4.35M | $15.68M |
| 2017-12-31 | $250.99M | (m) | $5.38M | $9.87M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |